{
  "meta": {
    "disclaimer": "Do not rely on openFDA to make decisions regarding medical care. While we make every effort to ensure that data is accurate, you should assume all results are unvalidated. We may limit or otherwise restrict your access to the API in line with our Terms of Service.",
    "terms": "https://open.fda.gov/terms/",
    "license": "https://open.fda.gov/license/",
    "last_updated": "2026-04-01",
    "results": {
      "skip": 0,
      "limit": 1,
      "total": 1
    }
  },
  "results": [
    {
      "status": "Terminated",
      "city": "Corona",
      "state": "CA",
      "country": "United States",
      "classification": "Class II",
      "openfda": {},
      "product_type": "Drugs",
      "event_id": "67200",
      "recalling_firm": "Watson Laboratories Inc",
      "address_1": "132 Business Center Dr",
      "address_2": "",
      "postal_code": "92880-1724",
      "voluntary_mandated": "Voluntary: Firm initiated",
      "initial_firm_notification": "Letter",
      "distribution_pattern": "Nationwide",
      "recall_number": "D-397-2014",
      "product_description": "Carisoprodol Tablets, USP, CIV, 350 mg, 500 count bottle, Rx only. Manufactured by Watson Pharma Private Ltd, Verna, Salcette, Goa, 403 722 INDIA.  Distributed by: Watson Pharma Ltd, Parsippany, NJ 07054. NDC 0591-5513-05.",
      "product_quantity": "4,439 bottles",
      "reason_for_recall": "Presence of Foreign Substance; metal particulates were visually observed in the tablets.",
      "recall_initiation_date": "20131223",
      "center_classification_date": "20140106",
      "termination_date": "20140804",
      "report_date": "20140115",
      "code_info": "Lot # 244152A, exp 01/15.",
      "more_code_info": ""
    }
  ]
}